Quantcast
Last updated on April 16, 2014 at 12:43 EDT

Latest Lupin Stories

2014-03-27 12:30:57

Specialty Ophthalmic Company in Mexico; Enters the Latin American Market MUMBAI, India and BALTIMORE, March 27, 2014 /PRNewswire/ -- Pharma Major Lupin Limited announced today the acquisition of 100% equity stake in Laboratorios Grin, S.A. De C.V. (Grin), Mexico, subject to certain closing conditions. The acquisition marks Lupin's foray into the high growth Mexican and the larger Latin American pharmaceuticals market. Mexico is one of the fastest growing pharmaceutical markets in the...

2014-02-18 08:31:12

MUMBAI, India and BALTIMORE, February 18, 2014 /PRNewswire/ -- Pharma major Lupin, today announced the appointment of Dr. Maurice Chagnaud as its President, Europe and Head of Inhalation Strategy. He will be based at Schaffhausen, Switzerland. Dr. Chagnaud has over 20 years of experience in Pharmaceutical business in Europe having worked with Teva and Merck Generics. He joins Lupin from Israeli drug major, Teva, where he was the Senior Vice President, Central & Eastern...

2013-12-18 12:25:41

MUMBAI and BALTIMORE, December 18, 2013 /PRNewswire/ -- Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary Lupin Pharmaceuticals Inc. has launched its Abacavir Sulfate, Lamivudine, and Zidovudine Tablets, 300 mg (base) / 150 mg / 300 mg in the US after the US District Court for the District of Delaware ruled that the Lupin's generic version of Trizivir(R) did not infringe on patents. Lupin had earlier received approval for the same. Lupin's...

2013-11-11 08:27:44

MUMBAI and BALTIMORE, November 11, 2013 /PRNewswire/ -- Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals, Inc. (LPI) has launched its generic Rabeprazole Sodium delayed-release tablets, 20mg. Lupin had earlier received final approval from the US FDA for the same. Lupin's Rabeprazole Sodium delayed-release tablets, 20mg, are the generic equivalent of Eisai Inc.'s Aciphex(R) delayed-release tablets, 20mg, and are indicated...

2013-10-03 12:25:56

MUMBAI, India and BALTIMORE, October 3, 2013 /PRNewswire/ -- Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals, Inc. (LPI), has launched its generic Gatifloxacin Ophthalmic Solution, 0.5%. Lupin had earlier received final approval from the United States Food and Drugs Administration (US FDA) to market a generic version of Allergan Inc.'s Zymaxid(TM) Ophthalmic Solution, 0.5%. Lupin's Gatifloxacin Ophthalmic solution 0.5% is...

2013-09-23 12:26:17

Inks Strategic Agreement to Promote Locoid® Lotion to US Pediatricians MUMBAI, India and BALTIMORE, September 23, 2013 /PRNewswire/ -- Pharmaceutical Major, Lupin Ltd. and its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) announced today that it has signed a strategic co-promotion agreement with US based Onset Dermatologics, LLC ("Onset") that grants Lupin exclusive rights to promote Onset's Locoid(R) Lotion (hydrocortisone butyrate 0.1%) to Pediatricians in...

2013-02-04 23:01:41

Pharmaceutical Operations Provider (POP) announced today that Lupin Pharmaceuticals of Baltimore, MD has begun deploying iPoint Mobile for iPad. All 160 sales representatives are upgrading to iPads configured with POP´s intuitive iPoint Mobile CRM with integrated sample call management, electronic signature, GPS, and eDetailing. (PRWEB) February 04, 2013 POP has been providing sales force operations software and consulting services for Lupin since 2006, when the company switched from...

2013-01-31 12:28:07

MUMBAI, January 31, 2013 /PRNewswire/ -- Record Sales and Profits Net Sales up 38%, EBITDA up 68%, PAT up 43% BSE: 500257 | NSE: LUPIN | REUTERS: LUPIN.BO | BLOOMBERG: LPC IN Pharma Major, Lupin Ltd. reported its performance for the third quarter ended 31st December, 2012. These unaudited results were taken on record by the Board of Directors at a meeting in Mumbai today. -...

2012-06-05 02:27:54

MUMBAI, India and BALTIMORE, June 5, 2012 /PRNewswire/ -- Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received approval for SUPRAX(R) (Cefixime) Capsules 400 mg from the United States Food and Drugs Administration (FDA). Lupin expects to commence shipping the product in the near future. The approval will expand Lupin's range of SUPRAX(R) dosage forms available to treat the approved indications in...

2011-03-04 00:00:29

Bringing revolution on to the mobile games, Thief Lupin achieved the top 1 free game in US market and the top 10 games in more than 20 countries. Palo Alto, CA (PRWEB) March 3, 2011 A simple touch and tap will take your thief aboard the high security buildings like the Empire State Building, the Neuschwanstein castle and even the pyramids where he will, of course, have to dodge the protecting infrastructure like infrared blocks that burn his lifeline, flying spears and bugs on the attack,...